Anti-Nausea Drugs for Dogs: Vet Guide

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Anti-nausea drugs for dogs are prescription medications that block the specific receptor signals driving nausea and vomiting. The four drugs veterinarians reach for most often are maropitant, a neurokinin-1 (NK1) receptor antagonist, ondansetron and dolasetron, which are 5-HT3 receptor antagonists, and metoclopramide, a dopamine D2 receptor antagonist that also speeds up stomach emptying. Each one targets a different part of the vomiting reflex, so they are not interchangeable. Maropitant is the standard choice for acute vomiting and motion sickness, metoclopramide fits gastric stasis and delayed stomach emptying, and the 5-HT3 antagonists are used most often for chemotherapy-related or postoperative nausea. This guide explains how each drug works, what it is labeled for, how it is given, which dogs should not receive it, and how to compare them with your veterinarian.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

At a Glance

All four drugs require a veterinary diagnosis before use. None of them treats the underlying cause of vomiting, and giving one without knowing why a dog is vomiting can hide a serious problem such as a foreign body, pancreatitis, or toxin exposure.

What Nausea and Vomiting Mean in Dogs

Vomiting is a reflex, not a disease. A dedicated control center in the brainstem, the vomiting center, coordinates the sequence of events that ends in expulsion of stomach contents. That center receives input from several places. The chemoreceptor trigger zone sits outside the blood-brain barrier and samples the blood for toxins, drugs, and metabolic waste. The vestibular system in the inner ear reports balance information, which is why motion sickness and vestibular disease both cause nausea. The gastrointestinal tract itself sends signals through vagal and sympathetic nerves when it is irritated or distended. Finally, higher brain centers contribute the sensation we call nausea.

Each of these input pathways uses different neurotransmitters. Substance P acts at NK1 receptors in the vomiting center and the chemoreceptor trigger zone. Serotonin acts at 5-HT3 receptors on vagal afferents and in the chemoreceptor trigger zone. Dopamine acts at D2 receptors in the chemoreceptor trigger zone. Because each drug class blocks a different receptor, a drug that works well for one trigger may do very little for another.

Nausea in dogs is harder to measure than vomiting because dogs cannot describe how they feel. Veterinarians rely on a set of observable behaviors. These include excessive salivation, repeated lip licking, hard swallowing, restlessness, vocalization, lethargy, and a hunched posture. Researchers have also measured blood markers such as arginine vasopressin (AVP) and cortisol, which rise with nausea and fall when it is controlled [1][2]. This matters to owners because a dog can be deeply nauseated without ever vomiting, and that dog still needs treatment.

How the Main Anti-Nausea Drugs Work

Maropitant: NK1 Receptor Antagonist

Maropitant blocks substance P from binding to NK1 receptors in the central nervous system. Substance P is one of the final common messengers in the vomiting reflex, which is why maropitant suppresses vomiting triggered from many different directions at once. In a controlled study using a low-dose cisplatin model, no dog treated with maropitant vomited during the observation period, compared with an average of seven vomits in the placebo group [1]. A separate study that compared maropitant against metoclopramide, ondansetron, and chlorpromazine found maropitant was superior to ondansetron at preventing centrally triggered emesis from apomorphine, and superior to metoclopramide and chlorpromazine at preventing peripherally triggered emesis from syrup of ipecac [3]. That broad coverage is the main reason maropitant has become the default antiemetic in small animal practice.

Maropitant is labeled for acute vomiting and for vomiting associated with motion sickness. It is also widely used to prevent vomiting tied to surgery, opioid premedication, and chemotherapy. In a study of dogs premedicated with hydromorphone, none of the maropitant-treated dogs vomited, retched, or showed signs of nausea, while every dog in the saline group vomited, retched, or showed nausea signs [4]. Timing matters. Vomiting was significantly decreased when maropitant was given 15 minutes before hydromorphone and prevented when given 30 minutes before, but nausea signs only dropped significantly when maropitant was given a full 60 minutes ahead of the opioid [5]. Oral maropitant given two hours before premedication also sharply reduced vomiting compared with placebo [6].

Ondansetron and Dolasetron: 5-HT3 Receptor Antagonists

Ondansetron and dolasetron block serotonin at 5-HT3 receptors. These receptors are concentrated on vagal nerve endings in the gut and in the chemoreceptor trigger zone, which is why this class works best when nausea originates from the gastrointestinal tract or from drugs that release serotonin. Chemotherapy drugs are the classic example, and postoperative nausea is another.

Ondansetron has a specific and well-documented role in nausea that is not tied to vomiting. In dogs with vestibular syndrome, ondansetron significantly reduced the intensity of nausea-like behavior within two hours of intravenous administration, including salivation, lip licking, restlessness, and lethargy [7]. A follow-up placebo-controlled crossover study confirmed clinical resolution of nausea one hour after ondansetron and a corresponding drop in serum AVP [2]. This is an important distinction. Maropitant and metoclopramide are commonly used for vestibular disease, but the published evidence shows ondansetron is the drug that reliably controls the nausea component of that condition.

Ondansetron's weakness is oral absorption. A study of hospitalized dogs with naturally occurring nausea found that plasma ondansetron concentrations after oral dosing were often below the limit of quantification, and six of twenty-four dogs never had detectable drug at any time point [8]. Nausea scores still improved over time in that population, but the poor bioavailability is a real limitation. When a dog needs reliable ondansetron levels, the intravenous route is more dependable.

Dolasetron belongs to the same class and is used intravenously for chemotherapy-associated and postoperative nausea and vomiting. It shares the 5-HT3 mechanism with ondansetron, so the two are not typically combined.

Metoclopramide: D2 Antagonist and Prokinetic

Metoclopramide blocks dopamine at D2 receptors in the chemoreceptor trigger zone and, at higher doses, at 5-HT3 receptors as well. It also has prokinetic activity. It increases the tone of the lower esophageal sphincter, speeds gastric emptying, and improves coordination between the stomach and the small intestine. That combination makes it the logical choice when vomiting is tied to gastric stasis or delayed emptying rather than to a central trigger.

Metoclopramide's antiemetic strength is narrower than maropitant's. In a head-to-head comparison, the incidence of emesis after morphine and acepromazine was 0 percent for maropitant, 38 percent for metoclopramide, and 71 percent for saline [9]. A larger European field study found that 97 percent of maropitant-treated dogs and 71 percent of metoclopramide-treated dogs did not vomit after treatment, and maropitant reduced the mean number of vomiting events more than metoclopramide did [10]. Metoclopramide still has a place, particularly for gastric motility problems, but it is not the strongest general-purpose antiemetic.

Timing also affects metoclopramide. When it was given subcutaneously 30 minutes before morphine and dexmedetomidine, continuous lip licking dropped to 6.7 percent of dogs compared with 80 percent in the control group, and salivation dropped to 13.3 percent compared with 66.7 percent [11]. Given at the same time as the opioid, the benefit was smaller. This suggests metoclopramide works best when it is on board before the trigger arrives.

Comparing the Four Drugs

The table above is a comparison framework, not a dosing guide. Doses belong in the hands of the prescribing veterinarian because they depend on the dog's weight, the route chosen, and the underlying condition.

Maropitant: Labeled Uses, Metabolism, and Cautions

Maropitant is the most studied antiemetic in veterinary medicine. It is labeled for acute vomiting and for vomiting associated with motion sickness. It is also used off-label for preoperative vomiting prevention, chemotherapy support, and parvoviral enteritis. In a study of dogs with parvoviral enteritis, metoclopramide, ondansetron, and maropitant were equally effective at reducing the frequency and severity of vomiting, with maropitant given once daily by subcutaneous injection [12]. In dogs receiving doxorubicin, oral maropitant for five days after treatment significantly reduced both the incidence and severity of vomiting and diarrhea compared with placebo [13].

Maropitant is metabolized in the liver. This is the single most important caution for owners to understand. A dog with hepatic impairment may clear the drug more slowly, which raises the risk of accumulation and adverse effects. If your dog has known liver disease, elevated liver enzymes, or is on other medications that stress the liver, your veterinarian needs that information before prescribing maropitant. The drug is generally well tolerated in healthy dogs, but the hepatic route of elimination means the liver status of the patient matters.

The most common practical complaint about maropitant is injection discomfort. In a randomized trial, 64.5 percent of dogs showed discomfort after subcutaneous maropitant injection, compared with 21.4 percent for dimenhydrinate and 7.1 percent for saline [14]. A separate study reported injection discomfort in 48 percent of maropitant-treated dogs versus 9.8 percent for metoclopramide and 4.8 percent for saline [9]. This is transient and does not affect the drug's safety, but owners should expect it and not interpret a reaction at the injection site as an allergic emergency.

Maropitant prevents vomiting but does not stop gastroesophageal reflux. In anesthetized dogs premedicated with acepromazine and hydromorphone, none of the maropitant-treated dogs vomited or retched, but the number of dogs with reflux was not different between the maropitant and saline groups [15]. This distinction matters for dogs undergoing anesthesia, because reflux can still occur even when vomiting is fully controlled.

Ondansetron and Dolasetron: When 5-HT3 Blockade Is the Right Tool

The 5-HT3 antagonists are the drugs of choice when nausea is the dominant problem rather than vomiting. Vestibular syndrome is the clearest example. Dogs with vestibular disease often show intense nausea behaviors while vomiting relatively little, and maropitant and metoclopramide do not appear to control that nausea well [2]. Ondansetron does. In an open-label study of sixteen dogs with vestibular syndrome-associated nausea, the intensity of nausea dropped significantly in all dogs two hours after intravenous ondansetron, with significant improvements in salivation, lip licking, restlessness, and lethargy [7]. A subsequent double-blinded, placebo-controlled crossover study confirmed the finding and showed serum AVP fell alongside the clinical improvement [2].

Chemotherapy is the other major indication. 5-HT3 antagonists were developed largely for chemotherapy-induced nausea, and that remains their strongest evidence base in human and veterinary medicine. Postoperative nausea is a third setting. A study of dogs undergoing laparoscopic gastropexy and castration found that nausea scores rose in both the ondansetron and saline groups after extubation, with no significant difference between them at the doses used [16]. That result is a useful reminder that not every postoperative nausea study shows a benefit, and that ondansetron's value is most consistent in vestibular and chemotherapy settings.

The main limitation of ondansetron in dogs is oral absorption. When twenty-four hospitalized dogs with naturally occurring nausea received oral ondansetron at various doses, half the samples in the lower-dose groups and 39 percent in the higher-dose groups fell below the limit of quantification, and a quarter of the dogs never had detectable drug [8]. If your dog needs ondansetron and is vomiting or has gastrointestinal disease that impairs absorption, the intravenous route is more reliable.

Dolasetron is the other 5-HT3 antagonist used in dogs. It is given intravenously and shares ondansetron's mechanism and general indications. Veterinary clinical experience with dolasetron is more limited than with ondansetron, and the two are not combined because they act at the same receptor.

Metoclopramide: The Prokinetic Option

Metoclopramide is the oldest of the four drugs and the one with the most routes of administration. It can be given intravenously, subcutaneously, orally, or as a constant rate infusion. That flexibility makes it useful in hospitalized patients who need continuous coverage.

Its defining feature is prokinetic activity. Metoclopramide increases lower esophageal sphincter tone, accelerates gastric emptying, and improves gastroduodenal coordination. For a dog with gastric stasis, delayed emptying after surgery, or a stomach that is not moving contents normally, metoclopramide addresses the motility problem and the nausea together. That is a different job than maropitant does. Maropitant silences the vomiting reflex. Metoclopramide moves the stomach.

Its antiemetic power is moderate. The morphine and acepromazine study showed 38 percent emesis with metoclopramide versus 0 percent with maropitant [9]. The European field study showed 71 percent of metoclopramide-treated dogs vomit-free versus 97 percent with maropitant [10]. In parvoviral enteritis, metoclopramide, ondansetron, and maropitant performed similarly when each was dosed appropriately [12]. The pattern is consistent. Metoclopramide works, but it is not the strongest single agent for general vomiting.

Timing improves its performance. Given 30 minutes before morphine and dexmedetomidine, metoclopramide cut continuous lip licking from 80 percent to 6.7 percent and salivation from 66.7 percent to 13.3 percent [11]. Given simultaneously with the opioid, the effect was weaker. This is practical information for owners whose dogs are scheduled for procedures involving opioid premedication.

Metoclopramide has a short duration of action, which is why it is often given two to three times daily or as a constant rate infusion. It should be used with caution when a gastrointestinal obstruction is suspected, because stimulating motility against a blockage can cause harm. Your veterinarian will rule that out before prescribing it.

How Veterinarians Choose Between Them

The choice comes down to what is driving the nausea and vomiting. The decision path below summarizes the main branches.

flowchart TD
    A[Dog has nausea or vomiting] --> B{Vomiting or nausea}
    B -->|Vomiting| C[Assess trigger]
    B -->|Nausea only| D[Consider ondansetron]
    C --> E{Trigger type}
    E -->|Motion or acute| F[Maropitant]
    E -->|Opioid or surgery| G[Maropitant first line]
    E -->|Chemotherapy| H[5 HT3 antagonist]
    E -->|Gastric stasis| I[Metoclopramide]
    D --> J[Check vestibular disease]
    J --> K[Ondansetron]
    F --> L[Recheck response]
    G --> L
    H --> L
    I --> L
    K --> L

A few principles guide that flow. Maropitant is the broadest and strongest single agent for acute vomiting, so it is the default when the trigger is unclear or when the cause is motion, opioids, or general acute vomiting. Ondansetron and dolasetron are reserved for situations where 5-HT3 signaling is the main driver, particularly chemotherapy and vestibular nausea. Metoclopramide is chosen when gastric motility is part of the problem, not just the vomiting reflex. In some patients, a veterinarian will combine drugs from different classes because the triggers overlap, but that decision requires a diagnosis.

Giving These Medications at Home

Maropitant comes as an oral tablet and as an injectable. The oral form is typically given once daily, and the tablet can be given with or without food. If your dog vomits shortly after receiving an oral dose, the drug may not have been absorbed, and you should contact your veterinarian rather than repeating the dose on your own.

Ondansetron oral tablets are absorbed poorly in dogs, so oral use is most reasonable when the dog is not actively vomiting and the goal is nausea control. If your dog is vomiting, the injectable route is more dependable, which usually means treatment in a clinic.

Metoclopramide oral tablets and liquid are usually given multiple times daily because of the short duration of action. Do not crush or split tablets unless your veterinarian or pharmacist confirms it is appropriate for that specific product.

Dolasetron is given intravenously in a clinical setting. It is not a take-home medication.

A few general rules apply to all four. Give the medication exactly as prescribed, do not adjust the dose based on how your dog looks that day, and do not stop a course early without asking. If your dog vomits the dose, do not give a second dose unless your veterinarian tells you to. Keep a simple log of when you gave the drug and what your dog did afterward. That record helps your veterinarian judge whether the drug is working.

Side Effects and What to Do About Them

Maropitant is generally well tolerated. The most common issue is discomfort at the injection site, reported in roughly half to two-thirds of dogs in controlled studies [14][9]. This is brief and does not require treatment. Oral maropitant can occasionally cause drooling, vomiting, or decreased appetite. Because maropitant is metabolized by the liver, any sign of jaundice, lethargy, or loss of appetite in a dog on maropitant should prompt a call to the veterinarian.

Ondansetron and dolasetron can cause constipation, headache-like signs that are hard to detect in dogs, and occasional gastrointestinal upset. In dogs, the more relevant concern is that oral ondansetron may not reach therapeutic blood levels, so a lack of improvement does not always mean the drug failed. It may mean the drug was not absorbed.

Metoclopramide can cause restlessness, agitation, and in some dogs, a change in behavior that owners describe as pacing or inability to settle. This is related to its dopamine-blocking activity. It can also cause drowsiness. If your dog becomes unusually agitated or restless after a metoclopramide dose, contact your veterinarian. Metoclopramide should not be used when a gastrointestinal obstruction is suspected.

Any sign of facial swelling, hives, difficulty breathing, or collapse after any of these medications is an emergency. Seek immediate veterinary care.

Which Dogs Should Not Receive These Drugs

Maropitant should be used with caution in dogs with hepatic impairment because the drug is cleared by the liver. Dogs below the minimum age on the product label should not receive it. Pregnant or breeding dogs should only receive it if the veterinarian judges the benefit to outweigh the risk.

Ondansetron and dolasetron should be used with caution in dogs with known hypersensitivity to 5-HT3 antagonists. Because they affect serotonin signaling, they should be used carefully in dogs on other serotonergic drugs, and your veterinarian needs a complete medication list.

Metoclopramide should not be used when a gastrointestinal obstruction, perforation, or hemorrhage is suspected, because its prokinetic effect can worsen those conditions. It should also be used cautiously in dogs with seizure disorders or on other drugs that affect dopamine signaling.

For all four drugs, the prescribing veterinarian needs to know every other medication and supplement your dog receives, including over-the-counter products. Drug interactions are one of the main reasons a medication that works well in one dog causes problems in another.

Questions to Ask Your Veterinarian

Before your dog starts an anti-nausea drug, ask these questions. What is the likely cause of the vomiting or nausea? Is this drug treating the symptom or the cause? How soon should I expect improvement, and what should I do if I do not see it? What side effects should I watch for at home? Does my dog's liver status change which drug is safe? Can this drug be combined with the other medications my dog takes? When should we recheck, and what signs mean I should come back sooner?

These questions matter because anti-nausea drugs can mask a worsening underlying problem. A dog that stops vomiting on maropitant but has a gastrointestinal foreign body is not improving. The drug is hiding the sign. That is why the diagnosis comes first and the antiemetic comes second.

Limitations and When to Contact a Veterinarian

This article is educational and is not a substitute for veterinary diagnosis or treatment. Individual dogs respond differently, and the right drug depends on the cause of the nausea, the dog's liver and kidney status, and the other medications involved. Only your veterinarian can examine your dog, run the necessary tests, and prescribe safely.

Contact a veterinarian promptly if your dog vomits more than a few times in a day, vomits blood or material that looks like coffee grounds, has a distended or painful abdomen, is lethargic or weak, refuses water, or shows signs of dehydration such as tacky gums or loss of skin elasticity. Seek emergency care immediately if your dog collapses, has difficulty breathing, has a seizure, or shows facial swelling after a medication. Puppies, senior dogs, and dogs with chronic liver or kidney disease should be evaluated sooner rather than later, because they have less reserve to handle a vomiting episode.

If your dog is already on an anti-nausea drug and the vomiting returns after an initial improvement, do not increase the dose on your own. Call your veterinarian. A returning sign can mean the underlying disease is progressing, and that needs a fresh assessment.

Frequently Asked Questions

What is the most effective anti-nausea drug for dogs?

Maropitant is the broadest and strongest single antiemetic for most acute vomiting in dogs, based on head-to-head studies against metoclopramide, ondansetron, and chlorpromazine. Ondansetron is more effective for nausea tied to vestibular disease and chemotherapy.

Can I give my dog human anti-nausea medication?

No. Do not give human anti-nausea medication to a dog without veterinary direction. The drugs discussed here are prescription veterinary medications, and human products can contain ingredients or doses that are unsafe for dogs.

How long does maropitant take to work?

Maropitant begins working within about an hour of subcutaneous injection. For prevention, it works best when given 30 to 60 minutes before the trigger, such as an opioid premedication.

Is metoclopramide the same as maropitant?

No. Metoclopramide blocks dopamine D2 receptors and speeds up stomach emptying. Maropitant blocks NK1 receptors and suppresses the vomiting reflex more broadly. They are different drugs with different jobs.

Why did my vet prescribe ondansetron instead of maropitant?

Ondansetron is often chosen when nausea is the main problem rather than vomiting, especially with vestibular disease or chemotherapy. Maropitant and metoclopramide do not control vestibular nausea well.

Can these drugs be used together?

Sometimes a veterinarian will combine drugs from different classes when the triggers overlap. Do not combine them on your own. The decision requires a diagnosis and a full medication review.

What should I do if my dog vomits after taking an anti-nausea pill?

Call your veterinarian. The pill may not have been absorbed, and repeating the dose without guidance can lead to overdosing. Your veterinarian may recommend an injectable form instead.

Are anti-nausea drugs safe for puppies?

Only under veterinary direction, and only if the puppy meets the minimum age on the product label. Puppies dehydrate faster than adult dogs, so vomiting in a puppy should be evaluated promptly.

Related Articles

• Cerenia Maropitant Anti-Nausea Dose: Motion Sickness Dosing Chart for Pets
• Cat Food Anti Hairball
• Dog Anti Itch Ear Drops
• Why Is My Dog licking carpet obsessively? Nausea-Related Licking Disorder
• Why Is My Dog grinding teeth? Bruxism Dental Pain and GI Nausea
• Ondansetron Antiemetic Dose: Nausea Dose for Cancer and Kidney Pets
• Alpha-Adrenoceptor Blockers: Vet Drug Guide
• Dog Antifungal Medication: Options, Doses, and Safety
• IV Fluids: Types, Rates, and Vet Calculations

Sources

1. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
2. Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
3. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
4. Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
5. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
6. Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
7. The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.
8. Plasma Concentrations of Oral Ondansetron in Hospitalized Dogs Exhibiting Clinical Signs of Nausea.
9. A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
10. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
11. Effect of metoclopramide on nausea and emesis in dogs premedicated with morphine and dexmedetomidine.
12. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
13. Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.
14. Effectiveness of dimenhydrinate and maropitant in preventing preoperative emesis and nausea in healthy dogs sedated with hydromorphone and dexmedetomidine: a randomized, blinded trial.
15. Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
16. Effect of preoperative ondansetron on postoperative nausea in healthy dogs undergoing laparoscopic gastropexy and castration.